For the 4th year, Linda Huguelet, co-leader of the Chattanooga Multiple Myeloma Networking Group is joining over 25,000 hematologists and healthcare professionals from around the world at the 58th American Society of Hematology Annual Meeting and Exposition in San Diego on Dec. 2-5.
Ms. Huguelet is one of twelve cancer patients and support group leaders attending this year.
While at the conference, Ms. Huguelet will be brought up-to-date on the latest research, therapies, and tools available to myeloma patients. In turn, she will report the news to patients back home, using social media tools like blogs, Twitter, and video. You can follow on Twitter Linda at @IMFlindaMYELOMA.
Ms. Huguelet’s participation at the conference is sponsored by the International Myeloma Foundation.
Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affects production of red cells, white cells and stem cells and can damage bone. It’s currently incurable and is being contracted by an increasing number of people and is particularly affecting younger people, officials said.
Ms. Huguelet, a Signal Mountain resident, who was diagnosed with myeloma in 2010 at the age of 46, typically follows news from medical conferences online on the IMF website, said, “The amount of research taking place is so encouraging and there are many emerging new treatments under development. To many people, research is a pretty dry subject, but its progress is very personal to me.”
"She will pass along news about all the encouraging research taking place when the Chattanooga Multiple Myeloma Networking Group meets after the first of the year," officials said.
The Chattanooga Multiple Myeloma Networking Group meets the second Thursday of each month at 6 p.m. Meetings are held at the Memorial Center for Cancer Support located next to Memorial Hospital. Visit MyelomaChattanooga.org for more information on the group which provides information and support to patients and caregivers in the Chattanooga area.